Navigation Links
REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients
Date:7/9/2009

on in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to potential market for REMERON. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A "Risk Factors" in the Company's first quarter 2009 10-Q, filed May 1, 2009.

References:

  1. REMERON(R) Package Insert. Schering-Plough K.K.
  2. REMERON(R) (summary of product characteristics). Schering Corporation.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Diamyd(R) Phase III Study Approved for Younger Patients in the US
2. Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union
3. AACR 100th Annual Meeting Highlights Superior Ability of InNexus DXL-Modified Anti-CD20 Antibody to Attach and Kill NHL With Safety Comparable to Approved Antibody Therapies in Preclinical Studies
4. AV-1011 Bird Repellent to Protect Rice Seed Approved for Use in Louisiana and Missouri
5. DSM and Crucell Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6(R) Cell Line Proteins
6. Naglazyme Approved by Brazils National Health Surveillance Agency
7. Watsons GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
8. Neogens BetaStar(R) US Dairy Antibiotic Test Approved by FDA/NCIMS
9. First U.S. Implants of Newly Approved Embozene(TM) Color-Advanced Microspheres Embolization Platform
10. Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes
11. Pharmaxis Aridol Approved for Sale in Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... ORANGEBURG, N.Y. , May 26, 2015 /PRNewswire/ ... products and solutions, today announced that Oakwood Healthcare ... been selected as the winning entry in ... recognizing industry professionals who display excellence in building ... services (ES) teams in healthcare facilities.  ...
(Date:5/26/2015)... ANGELES , May 26, 2015 Mr. ... his family, thanks President Barack Obama and President ... during the time of loss of Dr. Rongxiang Xu ... humanitarian and a leader ahead of his time, Dr. Xu,s ... the community leave a legacy that will not be forgotten. ...
(Date:5/26/2015)... May 26, 2015 US-Australian drug discovery and development company, ... will present at the 2015 Marcum MicroCap Conference on ... at the Grand Hyatt Hotel. The Company,s ... is scheduled to begin at 9.30 a.m. ET and will be ... http://wsw.com/webcast/marcum3/nvgn . The annual Marcum MicroCap Conference ...
(Date:5/25/2015)... TX (PRWEB) May 25, 2015 ... Hydrogen Chloride Industry is a professional and in-depth ... Hydrogen Chloride Market with a focus ... the hydrogen chloride market research are Linde Industrial ... Chemcial, Yuanhua Chemical, Shandong Xinlong Group, Longsheng Group, ...
Breaking Biology Technology:PDI Announces Winner in Delivering the Difference Contest 2PDI Announces Winner in Delivering the Difference Contest 3Dr. Rongxiang Xu, Beyond A Legend 2Novogen to Present at the 2015 Marcum Microcap Conference 2Novogen to Present at the 2015 Marcum Microcap Conference 3Novogen to Present at the 2015 Marcum Microcap Conference 4Global Hydrogen Chloride Industry 2015 Trends and Analysis Available in a New Report at DeepResearchReports.com 2Global Hydrogen Chloride Industry 2015 Trends and Analysis Available in a New Report at DeepResearchReports.com 3
... American Society of Clinical Oncology (ASCO) Meeting Show Fleximer(R) ... Prolonged Stable Disease in Refractory Tumors - , ... preliminary results of a Phase 1 clinical trial for ... at the 2009 Annual Meeting of the American Society ...
... , - Webinar on June 9 to discuss the prevalence ... at www.connecttoprotect.com - , ... Gastroenterological Association (AGA) Institute and Horizon Therapeutics, Inc. today launched ... about the gastrointestinal (GI) risks associated with the use of ...
... CHICAGO, June 1 UCB, Inc. and the ... of the 2009 Research Awards in Inflammatory Bowel Disease (IBD) ... research grant for their original clinical or basic research, totaling ... the CDWG Steering Committee and the awards were funded by ...
Cached Biology Technology:Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors 2Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors 3AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 2AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 3UCB and Crohn's Disease Working Group Award $175,000 in Research Grants to Gastroenterology Fellows 2
(Date:5/19/2015)... 19, 2015  Technology is rapidly advancing, outpacing enterprises, ... the cloud. Passwords and their management are soon to ... standards-based specifications such as those developed by the FIDO ... passwords presents for BYOD, COPE, IoT, and mobile payments, ... protocol. In response to the call ...
(Date:5/11/2015)... 2015  Synaptics Incorporated (NASDAQ: SYNA ), ... announced the appointment of Wajid Ali ... reporting to Rick Bergman , President and ... Officer, Kathleen Bayless , who announced her ... Ali brings extensive financial management expertise to Synaptics, ...
(Date:5/7/2015)... Fingerprint Cards (FPC) introduces ... FPC,s smallest touch fingerprint sensors to date.  ... integration on the backside of the phone, and ... to integrate touch fingerprint sensors in the OEMs, ... for module manufacturers to customize the look and ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... many aspects of who we are from the colour ... but how are the genes, and consequently the proteins they ... new group of molecules which control some of the fundamental ... developing new therapies for treating neurodegenerative diseases. The research, ...
... paper published today in Nature,s open access journal Scientific ... that male pseudoscorpions treated with the antibiotic tetracycline suffer significantly ... their untreated sons. They suggest that a similar effect could ... first research to show a transgenerational effect of antibiotics," David ...
... April 27, 2012 Aware, Inc. (NASDAQ: AWRE ), ... today reported financial results for its first quarter ended March 31, ... were $5.7 million, a decrease of 10% compared to $6.4 million ... quarter of 2012 was $1.1 million, or $0.05 per diluted share. ...
Cached Biology News:Doubling the information from the double helix 2University of Nevada, Reno first to show transgenerational effect of antibiotics 2Aware, Inc. Reports First Quarter 2012 Financial Results 2Aware, Inc. Reports First Quarter 2012 Financial Results 3Aware, Inc. Reports First Quarter 2012 Financial Results 4Aware, Inc. Reports First Quarter 2012 Financial Results 5
The sample holders for gels are used to hold gels in place in the multi-sample tray I, which is used with Molecular Imager FX imaging systems....
... is a single-step staining method for labeling ... flow cytometry. The kit contains all the ... cells including: positive and negative control cells ... rinsing buffers for processing individual steps in ...
... Zero -mr agarose is specifically ... detectable endoosmosis, and is recommended ... molecular weight proteins or complexes ... degrees of molecular sieving in ...
... The Sequi-Gen GT and PowerPac 3000 system, 220-240 ... a 38 x 50 cm vertical slab gel ... electrophoresis cell, which is capable of separating nucleic ... integral plate chamber (IPC) assembly (IPC and bonded ...
Biology Products: